CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) | ||||
| Revenues | $ 9,734 | $ 0 | $ 12,734 | $ 0 |
| Cost of Goods Sold | 4,950 | 0 | 6,050 | 0 |
| Gross Profit | 4,784 | 0 | 6,684 | 0 |
| Operating expenses: | ||||
| General and administrative | 1,997,822 | 949,293 | 5,145,857 | 2,557,935 |
| Stock-based compensation expense | 329,323 | 147,163 | 1,080,930 | 334,228 |
| Research and development | 459,847 | 566,655 | 992,491 | 1,052,650 |
| Total operating expenses | 2,786,992 | 1,663,111 | 7,219,278 | 3,944,813 |
| Loss from operations | (2,782,208) | (1,663,111) | (7,212,594) | (3,944,813) |
| Other income (expense): | ||||
| Other income (expense), net | 1,292 | 0 | 217,722 | 0 |
| Gain on debt extinguishment, net | 0 | 0 | 245,105 | 0 |
| Gain on fair value adjustment - derivatives, net | 0 | 0 | 1,040,000 | 0 |
| Interest expense | (201,943) | (227,475) | (2,340,085) | (399,381) |
| Amortization of interest - debt discount | (115,831) | (130,830) | (806,902) | (222,373) |
| Total other income (expense), net | (316,482) | (358,305) | (1,644,160) | (621,754) |
| Loss before provision for income taxes | (3,098,690) | (2,021,416) | (8,856,754) | (4,566,567) |
| Provision for income tax | 0 | 0 | 0 | 0 |
| Net loss | (3,098,690) | (2,021,416) | (8,856,754) | (4,566,567) |
| Net loss attributable to noncontrolling interest | 4 | 4 | 13 | 102 |
| Net loss attributable to SOBR Safe, Inc. | (3,098,686) | (2,021,412) | (8,856,741) | (4,566,465) |
| Deemed dividends related to underwritten public offering warrants down round provision | (5,005,857) | 0 | (5,005,857) | 0 |
| Deemed dividends related to Original Warrants and New Warrant down round provision | (3,495,583) | 0 | (3,495,583) | 0 |
| Net loss attributable to common stockholders | $ (11,600,126) | $ (2,021,412) | $ (17,358,181) | $ (4,566,465) |
| Basic and diluted loss per common share | $ (1.06) | $ (0.23) | $ (1.82) | $ (0.53) |
| Weighted average number of common shares outstanding | 10,973,759 | 8,660,401 | 9,516,637 | 8,658,014 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, before tax, of income (loss) attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before tax of income (loss) of subsidiary attributable to the parent entity. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate amount of net income allocated to general partners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|